Interacciones de Flucitosina

Flucitosina (Ancobon), antifúngico, tiene 12 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 0; moderadas: 3; leves: 9; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones moderadas (3)

  • Anfotericina BantifúngicoModerada

    Flucytosine Concurrent use of flucytosine may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion. (etiqueta de Anfotericina B, Interacciones medicamentosas)

  • GanciclovirantiviralModerada

    Other drugs associated with myelosuppression or nephrotoxicity (e.g., dapsone, doxorubicin, flucytosine, hydroxyurea, pentamidine, tacrolimus, trimethoprim/ sulfamethoxazole, vinblastine, vincristine and zidovudine) Unknown Because of potential for higher toxicity, coadministration with Ganciclovir should be considered only if the potential benefits are judged… (etiqueta de Ganciclovir, Interacciones medicamentosas)

  • ValganciclovirantiviralModerada

    Other drugs associated with myelosuppression or nephrotoxicity (e.g., adriamycin, dapsone, doxorubicin, flucytosine, hydroxyurea, pentamidine, tacrolimus, trimethoprim/ sulfamethoxazole, vinblastine, vincristine, and zidovudine) Unknown Because of potential for higher toxicity, coadministration with valganciclovir hydrochloride should be considered only if the… (etiqueta de Valganciclovir, Interacciones medicamentosas)

Menciones leves (9)

  • Clotrimazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Econazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Fluconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • FluorouraciloantimetabolitoLeve

    5-Fluorouracil is a metabolite of flucytosine. (etiqueta de Flucitosina, Advertencias)

  • Itraconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Ketoconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Miconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Posaconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

  • Voriconazolantifúngico azólicoLeve

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (etiqueta de Flucitosina, Interacciones medicamentosas)

Compruebe Flucitosina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.